Absence of Significant Germ Line p53 Mutations in Ovarian Cancer Patients

scientific article published on 01 September 1995

Absence of Significant Germ Line p53 Mutations in Ovarian Cancer Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1006/GYNO.1995.1244
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0090825885712449?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0090825885712449?httpAccept=text/plain
P698PubMed publication ID7672703

P2093author name stringB. Anderson
R. E. Buller
T. Niemann
J. S. Skilling
S. Kaliszewski
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectovarian cancerQ172341
germline mutationQ5552256
P304page(s)368-374
P577publication date1995-09-01
P1433published inGynecologic OncologyQ5625182
P1476titleAbsence of significant germ line p53 mutations in ovarian cancer patients
Absence of Significant Germ Line p53 Mutations in Ovarian Cancer Patients
P478volume58

Reverse relations

cites work (P2860)
Q61822365Correlation between mutations in p53 gene and protein expression in human lymphomas
Q53434842Field cancerization: why late "recurrent" ovarian cancer is not recurrent.
Q33542652Forth nightly review: hereditary ovarian carcinoma
Q36641252Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations
Q35355110Intronic TP53 Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families
Q24801244Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B
Q53670536Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.
Q35875339Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium.
Q24806016The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia

Search more.